IRadimed Corp
NASDAQ:IRMD

Watchlist Manager
IRadimed Corp Logo
IRadimed Corp
NASDAQ:IRMD
Watchlist
Price: 52.75 USD -1.2%
Market Cap: 668.3m USD
Have any thoughts about
IRadimed Corp?
Write Note

Net Margin
IRadimed Corp

26.1%
Current
24%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
26.1%
=
Net Income
18.6m
/
Revenue
71.3m

Net Margin Across Competitors

Country US
Market Cap 668.3m USD
Net Margin
26%
Country US
Market Cap 205.2B USD
Net Margin
14%
Country US
Market Cap 193.1B USD
Net Margin
29%
Country US
Market Cap 148.6B USD
Net Margin
16%
Country US
Market Cap 132.9B USD
Net Margin
11%
Country IE
Market Cap 109.9B USD
Net Margin
13%
Country US
Market Cap 64.8B USD
Net Margin
9%
Country DE
Market Cap 56.6B EUR
Net Margin
8%
Country CN
Market Cap 326.2B CNY
Net Margin
33%
Country US
Market Cap 42.2B USD
Net Margin
74%
Country US
Market Cap 37.7B USD
Net Margin
9%
No Stocks Found

IRadimed Corp
Glance View

Market Cap
668.3m USD
Industry
Health Care

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging (MRI) compatible medical devices. The company is headquartered in Winter Springs, Florida and currently employs 110 full-time employees. The company went IPO on 2014-07-16. Its MRidium 3860+ MRI Compatible IV infusion pump system provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The firm sells its products primarily to hospitals and acute care facilities, both in the United States and internationally.

IRMD Intrinsic Value
41.66 USD
Overvaluation 21%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
26.1%
=
Net Income
18.6m
/
Revenue
71.3m
What is the Net Margin of IRadimed Corp?

Based on IRadimed Corp's most recent financial statements, the company has Net Margin of 26.1%.